Strain Data Sheet

RBRC09995

Strain Information

Image
BRC No.RBRC09995
Type
SpeciesMus musculus
Strain nameB6.Cg-Mapt<tm1.1(MAPT)Tcs>
Former Common namehTau KI mouse
H-2 Haplotype
ES Cell lineiTL BA1 [C57BL/6N Tac x 129S6/SvEvTac]
Background strain
Appearance
Strain development
Strain description
Colony maintenance
References
Humanization of the entire murine Mapt gene provides a murine model of pathological human tau propagation.
Takashi Saito, Naomi Mihira, Yukio Matsuba, Hiroki Sasaguri, Shoko Hashimoto, Sneha Narasimhan, Bin Zhang, Shigeo Murayama, Makoto Higuchi, Virginia M Y Lee, John Q Trojanowski, Takaomi C Saido
J. Biol. Chem., 294(34):12754-12765 (2019). 31273083

Tau binding protein CAPON induces tau aggregation and neurodegeneration.
Shoko Hashimoto, Yukio Matsuba, Naoko Kamano, Naomi Mihira, Naruhiko Sahara, Jiro Takano, Shin-Ichi Muramatsu, Takaomi C Saido, Takashi Saito
Nat. Commun., 10(1):2394 (2019). 31160584

Human MAPT knockin mouse models of frontotemporal dementia for the neurodegenerative research community.
Takahiro Morito, Mohan Qi, Naoko Kamano, Hiroki Sasaguri, Sumi Bez, Martha Foiani, Karen Duff, Seico Benner, Toshihiro Endo, Hiroshi Hama, Hiroshi Kurokawa, Atushi Miyawaki, Hiroshi Mizuma, Naruhiko Sahara, Masafumi Shimojo, Makoto Higuchi, Takaomi C Saido, Naoto Watamura
Cell Rep. Methods, 5(4):101024 (2025). 40220760

Health Report

Examination Date / Room / Rack2026-08-31Room:3-ARack:GSentinel mouse program
2026-06-22Room:3-ARack:GSentinel mouse program
2026-04-06Room:3-ARack:GSentinel mouse program
2026-01-19Room:3-ARack:GSentinel mouse program
2025-11-10Room:3-ARack:GSentinel mouse program
2025-09-01Room:3-ARack:GSentinel mouse program
2025-06-16Room:3-ARack:GSentinel mouse program
2025-04-07Room:3-ARack:GSentinel mouse program
2025-01-07Room:3-ARack:GSentinel mouse program

Gene

Gene SymbolGene NameChr.Allele SymbolAllele NamePromoterDiseases Related to This Gene
Frt
yeast FRT (flippase recombination target) site11
Frt
MAPT
microtubule-associated protein tau (human)11
MAPT
Mapt
microtubule-associated protein tau11
Mapt<tm1.1(MAPT)Tcs>
targeted mutation 1.1, Takaomi C. Saido
  • frontotemporal dementia(DisGeNET, MedGEN)

  • late-onset Parkinson disease(MedGEN)

  • Pick disease(DisGeNET, MedGEN)
  • more 2 Diseases
  • progressive supranuclear palsy-parkinsonism syndrome(MedGEN)

  • supranuclear palsy, progressive, 1(MedGEN)
  • loxP
    phage P1 loxP11
    loxP

    Phenotype

    Phenotype annotation from literatures by Mammalian phenotype ontology
    Detailed phenotype data

    Ordering Information

    Donor DNAhuman MAPT genomic DNA, yeast FRT site, Phage P1 loxP site, mouse Mapt genomic DNA
    Research applicationCre/loxP system
    FLP/frt system
    Specific Term and ConditionsThe BIOLOGICAL RESOURCE is the property of the RIKEN (The Institute of Physical and Chemical Research). RECIPIENT agrees to acknowledge Shoko HASHIMOTO, Takashi SAITO and Takaomi C. SAIDO in an acknowledgement section. RECIPIENT also agrees to cite Nature Communications 10: 2394 (2019) and Journal of Biological Chemistry, 294: 12754-12765 (2019) in all publications obtained using BIOLOGICAL RESOURCE. RECIPIENT agrees to acknowledge DEPOSITOR in all oral presentations and written publications as related to the BIOLOGICAL RESOURCE. RECIPIENT shall keep confidential any or all information marked CONFIDENTIAL that is received from DEPOSITOR and related to the BIOLOGICAL RESOURCE including oral discussions if they are reduced to writing within thirty (30) days and are marked "CONFIDENTIAL". For use of the BIOLOGICAL RESOURCE by a for-profit organization, the RECIPIENT must reach agreement on terms and conditions of use of it with DEPOSITOR (takaomi.saido@riken.jp) and must obtain a prior written consent from the DEPOSITOR. If any invention is conceived and reduced to practice by RECIPIENT in the performance of the Research Plan involving the BIOLOGICAL RESOURCE during the term of this MTA, RECIPIENT agrees to promptly inform the invention to DEPOSITOR and the parties will consult each other to determine inventorship and ownership of the invention based on the respective parties contribution to the invention, before filing an application for a patent. In the case of a jointly owned application, the parties will separately enter into a joint application agreement including the sharing of ownership, patent costs and licensing income, as well as the responsible party for the application procedures etc.
    DepositorTakaomi C. Saido (RIKEN CBS)
    Strain Statusan icon for Live miceLive mice
    an icon for Frozen embryosFrozen embryos
    an icon for Frozen spermFrozen sperm
    Strain AvailabilityCryopreserved sperm (within 1 month)
    Cryopreserved embryos (within 1 month)
    Live mouse (1 to 3 months)
    Additional Info.Necessary documents for ordering:
    1. Order form (Japanese / English)
    2. Category I MTA: MTA for distribution with RIKEN BRC (Japanese / English)
    3. Acceptance of responsibility for living modified organism (Japanese / English)
    Lab HP (RIKEN Bio Co., Ltd.
    Genotyping protocol -PCR-

    BRC mice in Publications

    Borcuk C, Héraud C, Herbeaux K, Diringer M, Panzer É, Scuto J, Hashimoto S, Saido TC, Saito T, Goutagny R, Battaglia D, Mathis C.
    Early memory deficits and extensive brain network disorganization in the AppNL-F/MAPT double knock-in mouse model of familial Alzheimer's disease.
    Aging Brain 2 100042(2022) 36908877
    Hiroki Sasaguri, Shoko Hashimoto, Naoto Watamura, Kaori Sato, Risa Takamura, Kenichi Nagata, Satoshi Tsubuki, Toshio Ohshima, Atsushi Yoshiki, Kenya Sato, Wakako Kumita, Erika Sasaki, Shinobu Kitazume, Per Nilsson, Bengt Winblad, Takashi Saito, Nobuhisa Iwata, Takaomi C. Saido
    Recent Advances in the Modeling of Alzheimer’s Disease
    Frontiers Neuroscience 16 (2022) 35431779
    Kasen A, Lövestam S, Breton L, Meyerdirk L, McPhail JA, Piche K, Louwrier A, Capan CD, Lee H, Scheres SHW, Henderson MX.
    Seed structure and phosphorylation in the fuzzy coat impact tau seeding competency.
    Nat Commun 16(1) 9240(2025) 41107248